SecBot SecBot
144 ·Filed Jun 8, 2026

SERA

SERA PROGNOSTICS, INC.
NEUTRAL
Impact 2/10
Horizonimmediate Processed4mo ago SEC0001950047-26-005782
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

No action warranted. The proposed sale is trivial in size and linked to RSU vesting, not a conviction-based disposal. Monitor future Form 4 filings for any larger open-market sales by officers or directors.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
SERA ▼ -5.63% at T+60d
NEUTRAL call -5.63% · α vs SPY -9.45% · entry $2.13 → $2.01
Entry = T+0 close
Jun 8, 2026
via day close
T+1d
-6.10%
call -6.10% · α -4.53%
$2.00
settled 5mo ago
T+5d
-13.62%
call -13.62% · α -16.03%
$1.84
settled 4mo ago
T+20d
-5.63%
call -5.63% · α -7.08%
$2.01
settled 4mo ago
T+60d
-5.63%
call -5.63% · α -9.45%
$2.01
settled 8w ago

Price Chart

Loading chart...

Executive Summary

Director Sandra AJ Lawrence filed a Form 144 notice of intent to sell 1,560 shares (~$3,572 at ~$2.29/sh), representing a minimal fraction of the $90M market cap. The shares were acquired via RSU vesting between April and June 2026 — this is a routine sale to cover tax obligations on equity compensation. No material signal for the stock.

Key Facts

  • Director Sandra AJ Lawrence filed Form 144 to sell 1,560 shares of common stock.
  • Sale value approximately $3,572.40, a negligible amount vs. $90M market cap.
  • Shares were acquired upon vesting of restricted stock units (RSUs) from 4/5/2026 to 6/5/2026.
  • Proposed sale date: 06/08/2026; exchange: NASDAQ.
  • This is a routine equity-compensation-related sale with no adverse signal.

Financial Impact

Proceeds of ~$3,572 — immaterial to the company

insider holdings (negligible reduction)

Risk Factors

  • None from this filing — sale may not even be executed as Form 144 is notice of intent only.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
89% bullish (9 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-005782
Document: 0001950047-26-005782-index.html0001950047-26-005782
Document: 0001950047-26-005782.txt0001950047-26-005782
11 reports for SERA
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for SERA — sortable, filterable
TypeNow
Oct 21, 2026
5d ago
Press Release
NEUTRAL ★ 1/10
$2.04awaiting T+60—$2.04 (−0.00%)
Oct 13, 2026
13d ago
144
NEUTRAL ★ 2/10
$2.07awaiting T+60—$2.04 (−1.45%)
Aug 19, 2026
9w ago
8-K
NEUTRAL ★ 3/10
$2.10awaiting T+60—$2.04 (−2.86%)
Jun 30, 2026
16w ago
8-K
NEUTRAL ★ 2/10
$2.03 $2.11▲ +3.94%▲ +0.98%$2.04 (+0.49%)
Jun 15, 2026
19w ago
Insider Cluster
BEARISH ★ 5/10
$1.86 $2.05▼ −10.22%▼ −9.22%$2.04 (−9.68%)
Jun 8, 2026
20w ago
144
NEUTRAL ★ 2/10
$2.13 $2.01▼ −5.63%▼ −9.45%$2.04 (−4.23%)
Jun 1, 2026
21w ago
8-K
NEUTRAL ★ 2/10
$2.04 $2.09▲ +2.45%▲ +1.33%$2.04 (−0.00%)
Apr 24, 2026
26w ago
DEFA14A
NEUTRAL ★ 2/10
$2.00 $2.08▲ +4.00%▼ −0.78%$2.04 (+2.00%)
Mar 6, 2026
33w ago
Insider Cluster
NEUTRAL ★ 3/10
$1.95 $2.19▲ +12.31%▼ −0.47%$2.04 (+4.62%)
Mar 6, 2026
33w ago
Insider Cluster
NEUTRAL ★ 3/10
$1.95 $2.19▲ +12.31%▼ −0.47%$2.04 (+4.62%)
Showing 10 of 11

US Market Status

Market Closed — Opens in 3h 57m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 8, 2026